Diabetes mellitus is chronic, progressive systemic disease characterized by dysfunction insulin function. Physiological
resistance to self injection or needle phobia has been seen across many populations in treatment of diabetes and require
injectable products two or three times a day. A series of discoveries led to the development of the hypodermic needle which
underwent significant changes. To overcome the problems related to needle based injections in treatment of diabetes there is
one technology NFIT (Needle freed injectable technology).Needle free delivery is done conveniently both for solids and liquids.
Various needle free injectors are available in the market like Biojector, vitajet, iject, cool.click etc. These formulations are designed
for better acceptability and patient convenience. They offer less pain and no needle phobia. They are ideally suited to chronic
injections of varying doses of insulin, proteins and monoclonal antibodies. And other novel drug formulations for diabetic
patients i.e. insulin micro pump, insulin transdermal patches, insulin nanopump, insulin pen, insulin tablets, insulin capsules,
insulin spray, inhalable insulin.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals